A small proportion of the HIV-infected infants develop de novo potent and broadly neutralizing antibodies (bnAbs) that respond to different and perhaps new epitopes of HIV-1 Env as early as one year post infection, compared with bnAb development in HIV + adults after 2-3 years of infection95. The gene discussed is ERVW-1; the disease is infection.